Abhay Prafulchandra Desai

Abhay Prafulchandra Desai

Director Director DIN 03016913
DIN 03016913 First appointment Sep 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2010
Shareholding value •••• Premium profile

About Abhay Prafulchandra Desai

Data last updated:

Abhay Prafulchandra Desai was a Director at Calyx Chemicals And Pharmaceuticals Limited (2010–2013) and Director at Unived Healthcare Products Private Limited (2019–2020). The companies operate in Pharma and E-Commerce.

DIN 03016913
Primary Designation Director
Industry Pharma
First Appointment 27 Sep 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Sep 20101986₹164 Cr (FY 2024)Active
Director05 Jun 20192012₹12.89 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Calyx Chemicals And Pharmaceuticals Limited
Unived Healthcare Products Private Limited
Premium access

Shareholding and investment profile for Abhay Prafulchandra Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhay Prafulchandra Desai

Abhay Prafulchandra Desai was first appointed on 27 Sep 2010 as Director at Calyx Chemicals And Pharmaceuticals Limited. The most recent appointment on record is 05 Jun 2019 at Unived Healthcare Products Private Limited.

Abhay Prafulchandra Desai held 2 earlier board appointments: Calyx Chemicals And Pharmaceuticals Limited (Director, 27 Sep 2010 to 03 Dec 2013); Unived Healthcare Products Private Limited (Director, 05 Jun 2019 to 20 Aug 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available